ReCell
ApprovedTerminated 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Carbon Dioxide Laser
Conditions
Carbon Dioxide Laser, Photoaging
Trial Timeline
Mar 22, 2023 → May 6, 2024
NCT ID
NCT05386368About ReCell
ReCell is a approved stage product being developed by AVITA Medical for Carbon Dioxide Laser. The current trial status is terminated. This product is registered under clinical trial identifier NCT05386368. Target conditions include Carbon Dioxide Laser, Photoaging.
Hype Score Breakdown
Clinical
30
Activity
20
Company
2
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05386368 | Approved | Terminated |